• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The side effects of penicillamine therapy in rheumatoid arthritis.

作者信息

Huskisson E C

出版信息

J Rheumatol Suppl. 1981 Jan-Feb;7:146-8.

PMID:6939876
Abstract

Penicillamine causes lots of problems. It is also a highly effective treatment which is capable of achieving long-term control of rheumatoid arthritis (RA). The physician's approach to the management of side effects is therefore determined by the patient's response as well as by adverse reactions. The severity of the adverse reaction and its natural history will influence the decision about treatment. There are just 3 options in a patient who develops a side effect due to penicillamine. Treatment may be stopped. It may be stopped and reintroduced, usually using a lower dose and cautious increases. Or it may be continued. Skillful management of side effects is an essential part of the treatment of RA with penicillamine. A therapeutic opportunity has been lost when treatment is stopped in a patient whose disease is controlled. The potential for side effects also influences the decision to use penicillamine and the surveillance required for patients receiving it.

摘要

相似文献

1
The side effects of penicillamine therapy in rheumatoid arthritis.
J Rheumatol Suppl. 1981 Jan-Feb;7:146-8.
2
Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.类风湿关节炎中的遗传标记与青霉胺毒性的关系。
J Rheumatol. 1986 Apr;13(2):269-73.
3
[Early recognition of adverse effects, especially of kidney lesions, in patients with progressive chronic polyarthritis under D-Penicillamine therapy].
Z Gesamte Inn Med. 1975 Aug 1;30(15):507-9.
4
Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.青霉胺治疗类风湿关节炎的长期随访:与HLA抗原相关的有效性和毒性
J Rheumatol. 1987 Dec;14(6):1115-9.
5
Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.长期低剂量青霉胺治疗类风湿关节炎的毒性。风湿性疾病合作系统研究组。
J Rheumatol. 1987 Feb;14(1):67-73.
6
[The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)].类风湿关节炎用青霉胺的基础治疗(作者译)
Munch Med Wochenschr. 1973 Nov 9;115(45):2047-50.
7
C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?类风湿关节炎患者的C1抑制剂缺乏——青霉胺不良反应风险增加?
J Rheumatol. 1996 Feb;23(2):378-81.
8
[Current status of D-penicillamine therapy in chronic polyarthritis].
Z Rheumatol. 1981 Mar-Apr;40(2):54-61.
9
Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
J Rheumatol. 1986 Apr;13(2):308-12.
10
An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy.青霉胺治疗类风湿性关节炎的评估及既往金制剂治疗的影响。
J Rheumatol. 1979 Jan-Feb;6(1):20-4.